SARS-CoV-2 biological samples for COVID-19 drug development

39 - Biobanques

Service description

SARS-CoV-2 drug development programs may require the use of human samples such as serum, swabs, or respiratory tract tissues. These human biological samples (HBS) are made available in some cases under authorization from health care facilities such as hospitals.

Additional services can be performed on the samples: DNA extractions, diagnostics kit testing, setting up specific protocols for the collection, etc.

This service is designed for Biotech companies developing SARS-CoV-2 new drugs.

Materials to provide

  • A specific regulatory process is required for approval of projects

    Further details on the project may be requested.

You will be able to exchange directly with the experts after filling in the form below.

Typical deliverables

  • Study following the specifications validated with the Expert

Get started with your COVID-19 human biological samples request

Please answer the fields below to be contacted by our team of scientists

section1-3
Back
home